Literature DB >> 11798978

Lupus vasculitis: differential diagnosis with antiphospholipid syndrome.

Theo Dov Golan1.   

Abstract

The inflammatory process of systemic lupus erythematosus (SLE) vasculitis occurs in up to 56% of patients with SLE, whereas the vaso-occlusive incidence of antiphospholipid syndrome in SLE (which is not exclusive of SLE vasculitis) reaches up to 15%. Both situations can be life-threatening, requiring the appropriate therapeutic approach. Aggressive anti-inflammatory therapy is used in the case of SLE vasculitis and aggressive antithrombotic/anticoagulant treatment in the other. However, often the differential diagnosis between the two entities is difficult to achieve, especially when a tissue biopsy to help establish the diagnosis is topographically difficult to obtain or is clinically contraindicated. Such situations are discussed and appropriate guidelines for a correct diagnosis suggested.

Entities:  

Mesh:

Year:  2002        PMID: 11798978     DOI: 10.1007/s11926-002-0019-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  34 in total

1.  Diagnosis of microvasculopathy in CNS vasculitis: value of perfusion and diffusion imaging.

Authors:  W T Yuh; T Ueda; J E Maley; J P Quets; M White; P Y Hahn; S Otake
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

Review 2.  Anti-P antibodies and neuropsychiatric lupus erythematosus.

Authors:  L Georgescu; D Mevorach; F C Arnett; J D Reveille; K B Elkon
Journal:  Ann N Y Acad Sci       Date:  1997-08-14       Impact factor: 5.691

3.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

4.  Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.

Authors:  M Sailer; W Burchert; C Ehrenheim; H G Smid; J Haas; K Wildhagen; U Wurster; H Deicher
Journal:  J Neurol       Date:  1997-03       Impact factor: 4.849

5.  High association of anticardiolipin antibodies with psychosis.

Authors:  M Schwartz; M Rochas; B Weller; A Sheinkman; I Tal; D Golan; N Toubi; I Eldar; B Sharf; D Attias
Journal:  J Clin Psychiatry       Date:  1998-01       Impact factor: 4.384

6.  Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves.

Authors:  L Ziporen; I Goldberg; M Arad; M Hojnik; J Ordi-Ros; A Afek; M Blank; Y Sandbank; M Vilardell-Tarres; I de Torres; A Weinberger; R A Asherson; Y Kopolovic; Y Shoenfeld
Journal:  Lupus       Date:  1996-06       Impact factor: 2.911

7.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

8.  Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus.

Authors:  E Toubi; M A Khamashta; A Panarra; G R Hughes
Journal:  Am J Med       Date:  1995-10       Impact factor: 4.965

Review 9.  The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment.

Authors:  R A Asherson
Journal:  Lupus       Date:  1998       Impact factor: 2.911

Review 10.  Laboratory testing in the evaluation and diagnosis of vasculitis.

Authors:  M L Cuellar; L R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.686

View more
  2 in total

Review 1.  Integrative neuroscience approach to neuropsychiatric lupus.

Authors:  Patricio T Huerta; Elizabeth L Gibson; Carson Rey; Tomás S Huerta
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 2.  Vasculitis associated with connective tissue disorders.

Authors:  Mittie K Doyle
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.